25 XP   0   0   10

Homology Medicines Inc
Buy, Hold or Sell?

Let's analyse Homology Medicines Inc together

PenkeI guess you are interested in Homology Medicines Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Homology Medicines Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Homology Medicines Inc

I send you an email if I find something interesting about Homology Medicines Inc.

Quick analysis of Homology Medicines Inc (30 sec.)










What can you expect buying and holding a share of Homology Medicines Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.26
Expected worth in 1 year
$-0.55
How sure are you?
31.0%

+ What do you gain per year?

Total Gains per Share
$-1.81
Return On Investment
-193.2%

For what price can you sell your share?

Current Price per Share
$0.93
Expected price per share
$0.66 - $0.97
How sure are you?
50%

1. Valuation of Homology Medicines Inc (5 min.)




Live pricePrice per Share (EOD)

$0.93

Intrinsic Value Per Share

$-21.19 - $-24.71

Total Value Per Share

$-19.93 - $-23.46

2. Growth of Homology Medicines Inc (5 min.)




Is Homology Medicines Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$72.9m$223.3m-$115.2m-106.6%

How much money is Homology Medicines Inc making?

Current yearPrevious yearGrowGrow %
Making money-$28.2m-$27k-$28.2m-99.9%
Net Profit Margin-3,374.0%-3.4%--

How much money comes from the company's main activities?

3. Financial Health of Homology Medicines Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#435 / 1031

Most Revenue
#576 / 1031

Most Profit
#815 / 1031

Most Efficient
#894 / 1031

What can you expect buying and holding a share of Homology Medicines Inc? (5 min.)

Welcome investor! Homology Medicines Inc's management wants to use your money to grow the business. In return you get a share of Homology Medicines Inc.

What can you expect buying and holding a share of Homology Medicines Inc?

First you should know what it really means to hold a share of Homology Medicines Inc. And how you can make/lose money.

Speculation

The Price per Share of Homology Medicines Inc is $0.9347. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Homology Medicines Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Homology Medicines Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.26. Based on the TTM, the Book Value Change Per Share is $-0.45 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Homology Medicines Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.28-29.7%-0.49-52.0%-0.02-2.3%-0.38-41.1%-0.32-34.4%
Usd Book Value Change Per Share-0.26-28.0%-0.45-48.3%0.043.8%-0.10-11.2%0.044.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.26-28.0%-0.45-48.3%0.043.8%-0.10-11.2%0.044.6%
Usd Price Per Share0.61-0.92-1.97-8.93-9.07-
Price to Earnings Ratio-0.55--0.49--0.43--10.63--10.38-
Price-to-Total Gains Ratio-2.32--2.10--1.98-84.15-63.05-
Price to Book Ratio0.48-0.52-0.50-2.49-1.58-
Price-to-Total Gains Ratio-2.32--2.10--1.98-84.15-63.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.9347
Number of shares1069
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.45-0.10
Usd Total Gains Per Share-0.45-0.10
Gains per Quarter (1069 shares)-482.64-111.92
Gains per Year (1069 shares)-1,930.58-447.68
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1931-19410-448-458
20-3861-38720-895-906
30-5792-58030-1343-1354
40-7722-77340-1791-1802
50-9653-96650-2238-2250
60-11583-115960-2686-2698
70-13514-135270-3134-3146
80-15445-154580-3581-3594
90-17375-173890-4029-4042
100-19306-193200-4477-4490

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%2.027.00.06.9%2.027.00.06.9%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%9.017.03.031.0%9.017.03.031.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.029.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%6.014.00.030.0%9.017.03.031.0%9.017.03.031.0%

Fundamentals of Homology Medicines Inc

About Homology Medicines Inc

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases in the United States. The company offers proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a nuclease-free gene editing mobility, gene therapy or for various genetic disorders. Its earlier stage product candidates comprising HMI-202, an investigational gene therapy which completed IND-enabling studies for the treatment of metachromatic leukodystrophy; and HMI-104 which completed IND-enabling studies. Homology Medicines, Inc. was incorporated in 2015 and is headquartered in Bedford, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-20 17:13:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Homology Medicines Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Homology Medicines Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Homology Medicines Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-3,374.0%+3,374.0%
TTM-3,374.0%YOY-3.4%-3,370.6%
TTM-3,374.0%5Y-3,386.4%+12.4%
5Y-3,386.4%10Y-2,547.8%-838.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM-3,374.0%-205.8%-3,168.2%
YOY-3.4%-262.1%+258.7%
5Y-3,386.4%-455.6%-2,930.8%
10Y-2,547.8%-589.0%-1,958.8%
1.1.2. Return on Assets

Shows how efficient Homology Medicines Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • -5.3% Return on Assets means that Homology Medicines Inc generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Homology Medicines Inc:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -16.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-16.0%+10.8%
TTM-16.0%YOY-1.6%-14.4%
TTM-16.0%5Y-9.8%-6.2%
5Y-9.8%10Y-14.3%+4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-12.5%+7.2%
TTM-16.0%-12.2%-3.8%
YOY-1.6%-11.2%+9.6%
5Y-9.8%-13.4%+3.6%
10Y-14.3%-14.7%+0.4%
1.1.3. Return on Equity

Shows how efficient Homology Medicines Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • -22.1% Return on Equity means Homology Medicines Inc generated $-0.22 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Homology Medicines Inc:

  • The MRQ is -22.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-22.1%TTM-26.9%+4.9%
TTM-26.9%YOY-2.6%-24.3%
TTM-26.9%5Y-13.8%-13.1%
5Y-13.8%10Y-20.2%+6.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.1%-15.8%-6.3%
TTM-26.9%-15.7%-11.2%
YOY-2.6%-13.9%+11.3%
5Y-13.8%-18.3%+4.5%
10Y-20.2%-19.2%-1.0%

1.2. Operating Efficiency of Homology Medicines Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Homology Medicines Inc is operating .

  • Measures how much profit Homology Medicines Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Homology Medicines Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-3,033.8%+3,033.8%
TTM-3,033.8%YOY-4,154.6%+1,120.8%
TTM-3,033.8%5Y-4,239.0%+1,205.2%
5Y-4,239.0%10Y-3,151.8%-1,087.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM-3,033.8%-210.1%-2,823.7%
YOY-4,154.6%-279.7%-3,874.9%
5Y-4,239.0%-459.9%-3,779.1%
10Y-3,151.8%-596.9%-2,554.9%
1.2.2. Operating Ratio

Measures how efficient Homology Medicines Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Homology Medicines Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM31.420-31.420
TTM31.420YOY42.942-11.522
TTM31.4205Y54.919-23.500
5Y54.91910Y42.072+12.848
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM31.4203.193+28.227
YOY42.9423.615+39.327
5Y54.9195.560+49.359
10Y42.0727.396+34.676

1.3. Liquidity of Homology Medicines Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Homology Medicines Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 7.25 means the company has $7.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Homology Medicines Inc:

  • The MRQ is 7.251. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.373. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ7.251TTM6.373+0.878
TTM6.373YOY10.144-3.772
TTM6.3735Y11.015-4.642
5Y11.01510Y10.200+0.815
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2513.986+3.265
TTM6.3734.440+1.933
YOY10.1445.552+4.592
5Y11.0156.158+4.857
10Y10.2006.492+3.708
1.3.2. Quick Ratio

Measures if Homology Medicines Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • A Quick Ratio of 10.89 means the company can pay off $10.89 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Homology Medicines Inc:

  • The MRQ is 10.891. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.931. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.891TTM9.931+0.960
TTM9.931YOY13.586-3.655
TTM9.9315Y15.797-5.866
5Y15.79710Y15.053+0.745
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.8913.638+7.253
TTM9.9314.168+5.763
YOY13.5865.515+8.071
5Y15.7976.012+9.785
10Y15.0536.209+8.844

1.4. Solvency of Homology Medicines Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Homology Medicines Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Homology Medicines Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.76 means that Homology Medicines Inc assets are financed with 76.2% credit (debt) and the remaining percentage (100% - 76.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Homology Medicines Inc:

  • The MRQ is 0.762. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.415. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.762TTM0.415+0.347
TTM0.415YOY0.181+0.234
TTM0.4155Y0.237+0.178
5Y0.23710Y0.308-0.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7620.335+0.427
TTM0.4150.330+0.085
YOY0.1810.267-0.086
5Y0.2370.367-0.130
10Y0.3080.378-0.070
1.4.2. Debt to Equity Ratio

Measures if Homology Medicines Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 319.4% means that company has $3.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Homology Medicines Inc:

  • The MRQ is 3.194. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.126. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ3.194TTM1.126+2.068
TTM1.126YOY0.223+0.903
TTM1.1265Y0.419+0.707
5Y0.41910Y0.422-0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.1940.376+2.818
TTM1.1260.398+0.728
YOY0.2230.334-0.111
5Y0.4190.429-0.010
10Y0.4220.476-0.054

2. Market Valuation of Homology Medicines Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Homology Medicines Inc generates.

  • Above 15 is considered overpriced but always compare Homology Medicines Inc to the Biotechnology industry mean.
  • A PE ratio of -0.55 means the investor is paying $-0.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Homology Medicines Inc:

  • The EOD is -0.843. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.548. Based on the earnings, the company is expensive. -2
  • The TTM is -0.488. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.843MRQ-0.548-0.295
MRQ-0.548TTM-0.488-0.061
TTM-0.488YOY-0.433-0.054
TTM-0.4885Y-10.631+10.143
5Y-10.63110Y-10.379-0.252
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.843-2.643+1.800
MRQ-0.548-2.418+1.870
TTM-0.488-2.742+2.254
YOY-0.433-4.123+3.690
5Y-10.631-6.257-4.374
10Y-10.379-6.478-3.901
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Homology Medicines Inc:

  • The EOD is -0.630. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.410. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.549. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.630MRQ-0.410-0.220
MRQ-0.410TTM-0.549+0.139
TTM-0.549YOY-0.981+0.432
TTM-0.5495Y-4.971+4.422
5Y-4.97110Y-6.082+1.111
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.630-3.244+2.614
MRQ-0.410-2.939+2.529
TTM-0.549-3.478+2.929
YOY-0.981-5.592+4.611
5Y-4.971-8.473+3.502
10Y-6.082-8.881+2.799
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Homology Medicines Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.48 means the investor is paying $0.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Homology Medicines Inc:

  • The EOD is 0.744. Based on the equity, the company is cheap. +2
  • The MRQ is 0.484. Based on the equity, the company is cheap. +2
  • The TTM is 0.520. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.744MRQ0.484+0.260
MRQ0.484TTM0.520-0.036
TTM0.520YOY0.500+0.020
TTM0.5205Y2.487-1.967
5Y2.48710Y1.584+0.903
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7442.124-1.380
MRQ0.4842.041-1.557
TTM0.5202.118-1.598
YOY0.5002.915-2.415
5Y2.4873.682-1.195
10Y1.5844.114-2.530
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Homology Medicines Inc.

3.1. Institutions holding Homology Medicines Inc

Institutions are holding 41.893% of the shares of Homology Medicines Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Temasek Holdings Ltd.9.74020.0192565099600
2023-12-315AM Venture Management, LLC7.81820.7316453591900
2023-12-31Vanguard Group Inc3.343101939590-106852-5.2214
2023-12-31Newtyn Management LLC2.41180.167139926013992600
2023-12-31BlackRock Inc1.878901090113-16175-1.4621
2023-09-30Citadel Advisors Llc1.51530.000287911215801121.9125
2023-12-31BML Capital Management LLC1.28950.34457481087481080
2023-12-31Vivo Capital, LLC0.63790.018437006800
2023-12-31Geode Capital Management, LLC0.5575032345900
2023-12-31George Kaiser Family Foundation0.52830.0378306514267194679.5371
2023-12-31ADAR1 Capital Management LLC0.50620.06382936762936760
2023-12-31Bank of America Corp0.32570188971-116084-38.0535
2023-12-31Renaissance Technologies Corp0.30090.0002174600-5400-3
2023-12-31State Street Corporation0.2306013380400
2023-12-31Tudor Investment Corp Et AL0.19930.000611562300
2023-12-31Susquehanna International Group, LLP0.1708099081-16308-14.1331
2023-12-31Acadian Asset Management LLC0.11460.000266515-63532-48.8531
2023-12-31FMR Inc0.114306631228004.4086
2023-12-31Northern Trust Corp0.113306576200
2023-09-30OUP Management Co., LLC0.11030.16846400000
Total 31.90671.551918511483+2544698+13.7%

3.2. Funds holding Homology Medicines Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.33050.0001135473800
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.9220.000553594300
2023-08-31Galileo - Biotech Innovation Fund S USD0.52241.115130367900
2024-01-31Fidelity Extended Market Index0.27140.000315778700
2023-09-30BlackRock Extended Mkt Composite0.16250.00089443900
2023-12-31BlackRock Extended Equity Market K0.14170.000482390-166-0.2011
2024-01-31Fidelity Total Market Index0.1060.00016162700
2024-01-31Fidelity Series Total Market Index0.08120.00014719000
2024-02-29Fidelity® Small Cap Enhanced Index0.06940.007340370-699-1.702
2023-12-31Franklin U.S. Small Cap Equity I0.06740.02513915500
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05990.00033484400
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.05310.00013084400
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.05310.000130844-1364457-97.7894
2024-01-31Fidelity Nasdaq Composite Index0.05050.00012935100
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04810.000327985530.1897
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04750.00032760300
2023-12-31Northern Trust Extended Eq Market Idx0.04750.00032760300
2023-12-31BlackRock U.S. Equity Market F0.03950.000122933410.1791
2023-12-31Fidelity VIP Disciplined Small Cap Init0.03860.00362243900
2024-01-31Schwab Total Stock Market Index0.03780.00012197100
Total 5.15011.15512993735-1365228-45.6%

3.3. Insider Transactions

Insiders are holding 9.29% of the shares of Homology Medicines Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-09Arthur TzianabosSELL130370.57
2024-01-03Paul AllowaySELL72800.57
2023-09-06Albert SeymourSELL14481.15
2023-08-02Julie JordanSELL991.31

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Homology Medicines Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.262-0.451+72%0.036-831%-0.105-60%0.043-705%
Book Value Per Share--1.2561.860-32%3.843-67%3.339-62%2.726-54%
Current Ratio--7.2516.373+14%10.144-29%11.015-34%10.200-29%
Debt To Asset Ratio--0.7620.415+84%0.181+320%0.237+221%0.308+148%
Debt To Equity Ratio--3.1941.126+184%0.223+1332%0.419+662%0.422+656%
Dividend Per Share----0%-0%-0%-0%
Eps---0.277-0.486+75%-0.022-92%-0.384+38%-0.321+16%
Free Cash Flow Per Share---0.371-0.416+12%-0.494+33%-0.460+24%-0.361-3%
Free Cash Flow To Equity Per Share---0.371-0.415+12%-0.491+32%-0.233-37%-0.047-87%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---24.714--------
Intrinsic Value_10Y_min---21.189--------
Intrinsic Value_1Y_max---1.950--------
Intrinsic Value_1Y_min---1.915--------
Intrinsic Value_3Y_max---6.259--------
Intrinsic Value_3Y_min---5.967--------
Intrinsic Value_5Y_max---11.053--------
Intrinsic Value_5Y_min---10.225--------
Market Cap54337382.450+35%35345168.00053671753.875-34%114522995.000-69%519082741.525-93%527016260.362-93%
Net Profit Margin----33.7400%-0.0340%-33.8640%-25.4780%
Operating Margin----30.3380%-41.5460%-42.3900%-31.5180%
Operating Ratio---31.420-100%42.942-100%54.919-100%42.072-100%
Pb Ratio0.744+35%0.4840.520-7%0.500-3%2.487-81%1.584-69%
Pe Ratio-0.843-54%-0.548-0.488-11%-0.433-21%-10.631+1839%-10.379+1793%
Price Per Share0.935+35%0.6080.923-34%1.970-69%8.929-93%9.066-93%
Price To Free Cash Flow Ratio-0.630-54%-0.410-0.549+34%-0.981+140%-4.971+1114%-6.082+1385%
Price To Total Gains Ratio-3.570-54%-2.322-2.096-10%-1.984-15%84.146-103%63.048-104%
Quick Ratio--10.8919.931+10%13.586-20%15.797-31%15.053-28%
Return On Assets---0.053-0.160+204%-0.016-69%-0.098+87%-0.143+172%
Return On Equity---0.221-0.269+22%-0.026-88%-0.138-37%-0.202-9%
Total Gains Per Share---0.262-0.451+72%0.036-831%-0.105-60%0.043-705%
Usd Book Value--72991000.000108119000.000-32%223395250.000-67%194124100.000-62%158466925.310-54%
Usd Book Value Change Per Share---0.262-0.451+72%0.036-831%-0.105-60%0.043-705%
Usd Book Value Per Share--1.2561.860-32%3.843-67%3.339-62%2.726-54%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.277-0.486+75%-0.022-92%-0.384+38%-0.321+16%
Usd Free Cash Flow---21575000.000-24199000.000+12%-28736500.000+33%-26757250.000+24%-20986144.793-3%
Usd Free Cash Flow Per Share---0.371-0.416+12%-0.494+33%-0.460+24%-0.361-3%
Usd Free Cash Flow To Equity Per Share---0.371-0.415+12%-0.491+32%-0.233-37%-0.047-87%
Usd Market Cap54337382.450+35%35345168.00053671753.875-34%114522995.000-69%519082741.525-93%527016260.362-93%
Usd Price Per Share0.935+35%0.6080.923-34%1.970-69%8.929-93%9.066-93%
Usd Profit---16119000.000-28240250.000+75%-27000.000-100%-22072150.000+37%-18506720.345+15%
Usd Revenue---289000.000-100%802000.000-100%2135150.000-100%1599551.724-100%
Usd Total Gains Per Share---0.262-0.451+72%0.036-831%-0.105-60%0.043-705%
 EOD+5 -3MRQTTM+20 -11YOY+9 -225Y+10 -2110Y+7 -24

4.2. Fundamental Score

Let's check the fundamental score of Homology Medicines Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.843
Price to Book Ratio (EOD)Between0-10.744
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.891
Current Ratio (MRQ)Greater than17.251
Debt to Asset Ratio (MRQ)Less than10.762
Debt to Equity Ratio (MRQ)Less than13.194
Return on Equity (MRQ)Greater than0.15-0.221
Return on Assets (MRQ)Greater than0.05-0.053
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Homology Medicines Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.975
Ma 20Greater thanMa 500.907
Ma 50Greater thanMa 1000.780
Ma 100Greater thanMa 2000.727
OpenGreater thanClose0.920
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets306,119
Total Liabilities233,128
Total Stockholder Equity72,991
 As reported
Total Liabilities 233,128
Total Stockholder Equity+ 72,991
Total Assets = 306,119

Assets

Total Assets306,119
Total Current Assets83,914
Long-term Assets222,205
Total Current Assets
Cash And Cash Equivalents 39,266
Short-term Investments 43,387
Other Current Assets 1,261
Total Current Assets  (as reported)83,914
Total Current Assets  (calculated)83,914
+/-0
Long-term Assets
Property Plant Equipment 650
Long-term Assets  (as reported)222,205
Long-term Assets  (calculated)650
+/- 221,555

Liabilities & Shareholders' Equity

Total Current Liabilities11,573
Long-term Liabilities221,555
Total Stockholder Equity72,991
Total Current Liabilities
Short-term Debt 1,318
Accounts payable 3,234
Other Current Liabilities 7,021
Total Current Liabilities  (as reported)11,573
Total Current Liabilities  (calculated)11,573
+/-0
Long-term Liabilities
Capital Lease Obligations 1,318
Long-term Liabilities  (as reported)221,555
Long-term Liabilities  (calculated)1,318
+/- 220,237
Total Stockholder Equity
Common Stock6
Retained Earnings -542,098
Accumulated Other Comprehensive Income -5
Other Stockholders Equity 615,088
Total Stockholder Equity (as reported)72,991
Total Stockholder Equity (calculated)72,991
+/-0
Other
Capital Stock6
Cash and Short Term Investments 82,653
Common Stock Shares Outstanding 58,017
Liabilities and Stockholders Equity 306,119
Net Debt -37,948
Net Invested Capital 72,991
Net Working Capital 72,341
Property Plant and Equipment Gross 650
Short Long Term Debt Total 1,318



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,219
0
0
0
137,530
129,078
270,315
268,397
259,094
233,026
341,156
316,759
310,567
288,788
258,238
228,362
263,737
234,697
258,918
230,816
211,721
310,958
284,609
262,651
228,470
197,881
169,337
140,063
306,119
306,119140,063169,337197,881228,470262,651284,609310,958211,721230,816258,918234,697263,737228,362258,238288,788310,567316,759341,156233,026259,094268,397270,315129,078137,53000014,219
   > Total Current Assets 
11,987
0
0
0
131,603
120,405
261,582
245,866
221,685
190,502
298,769
274,079
266,577
238,333
209,807
181,255
219,564
191,652
217,937
191,817
191,909
262,448
238,440
213,204
181,015
153,583
131,336
106,635
83,914
83,914106,635131,336153,583181,015213,204238,440262,448191,909191,817217,937191,652219,564181,255209,807238,333266,577274,079298,769190,502221,685245,866261,582120,405131,60300011,987
       Cash And Cash Equivalents 
11,392
0
0
0
51,575
46,213
94,961
36,038
38,220
40,839
115,566
77,559
53,774
143,372
167,636
178,003
217,431
104,416
116,313
95,829
108,382
248,127
176,188
43,162
33,986
39,454
76,797
29,111
39,266
39,26629,11176,79739,45433,98643,162176,188248,127108,38295,829116,313104,416217,431178,003167,636143,37253,77477,559115,56640,83938,22036,03894,96146,21351,57500011,392
       Short-term Investments 
0
0
0
0
78,084
70,519
160,548
201,506
176,517
147,128
180,230
192,113
208,614
91,557
39,007
0
0
84,233
96,980
91,722
47,491
7,999
49,335
157,912
141,040
110,571
50,274
74,187
43,387
43,38774,18750,274110,571141,040157,91249,3357,99947,49191,72296,98084,2330039,00791,557208,614192,113180,230147,128176,517201,506160,54870,51978,0840000
       Net Receivables 
0
0
0
0
0
0
0
0
800
200
300
300
400
400
600
400
400
300
200
100
0
600
1,300
1,800
300
0
100
0
0
0010003001,8001,300600010020030040040060040040030030020080000000000
       Other Current Assets 
595
0
0
0
1,945
3,672
6,074
8,322
6,948
2,535
2,973
4,407
4,189
3,404
3,164
3,252
2,133
3,003
4,644
4,266
7,129
6,322
12,917
12,130
5,989
3,558
4,265
3,023
1,261
1,2613,0234,2653,5585,98912,13012,9176,3227,1294,2664,6443,0032,1333,2523,1643,4044,1894,4072,9732,5356,9488,3226,0743,6721,945000595
   > Long-term Assets 
0
0
0
0
5,927
8,673
8,732
22,530
37,409
42,524
42,387
42,680
43,990
50,455
48,431
47,107
44,173
43,045
40,981
38,999
19,812
48,510
46,169
49,447
47,455
44,298
38,001
33,428
222,205
222,20533,42838,00144,29847,45549,44746,16948,51019,81238,99940,98143,04544,17347,10748,43150,45543,99042,68042,38742,52437,40922,5308,7328,6735,9270000
       Property Plant Equipment 
1,956
0
0
0
3,154
3,828
6,942
20,741
35,637
40,984
41,113
41,406
42,716
49,181
47,157
45,833
42,899
41,771
39,707
37,725
17,859
17,595
16,871
22,315
21,641
21,262
20,682
19,471
650
65019,47120,68221,26221,64122,31516,87117,59517,85937,72539,70741,77142,89945,83347,15749,18142,71641,40641,11340,98435,63720,7416,9423,8283,1540001,956
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,639
29,298
27,132
25,814
23,036
17,319
13,957
0
013,95717,31923,03625,81427,13229,29830,639000000000000000000000
       Long-term Assets Other 
0
0
0
0
2,773
4,845
1,790
1,790
1,772
1,540
1,274
1,274
1,274
1,274
1,274
1,274
1,274
1,274
1,274
1,274
1,953
276
29,298
-49,447
-47,455
-44,298
-38,001
13,957
0
013,957-38,001-44,298-47,455-49,44729,2982761,9531,2741,2741,2741,2741,2741,2741,2741,2741,2741,2741,5401,7721,7901,7904,8452,7730000
> Total Liabilities 
6,719
0
0
0
39,222
178,603
43,516
55,637
64,377
58,762
56,414
58,937
52,060
62,247
63,534
58,140
67,742
33,868
34,341
32,245
42,070
44,704
44,321
53,590
50,492
45,982
49,962
51,852
233,128
233,12851,85249,96245,98250,49253,59044,32144,70442,07032,24534,34133,86867,74258,14063,53462,24752,06058,93756,41458,76264,37755,63743,516178,60339,2220006,719
   > Total Current Liabilities 
6,378
0
0
0
8,862
9,442
10,876
18,574
25,433
17,647
15,491
18,682
12,374
17,452
19,564
17,178
22,658
17,808
19,534
18,705
17,226
20,802
20,734
25,252
22,576
18,507
22,939
25,292
11,573
11,57325,29222,93918,50722,57625,25220,73420,80217,22618,70519,53417,80822,65817,17819,56417,45212,37418,68215,49117,64725,43318,57410,8769,4428,8620006,378
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
2,331
2,413
2,497
2,501
2,323
2,142
1,959
246
435
410
1,489
1,561
1,626
1,701
1,778
1,318
1,3181,7781,7011,6261,5611,4894104352461,9592,1422,3232,5012,4972,4132,3310000000000000
       Accounts payable 
893
0
0
0
2,538
3,776
5,017
11,121
15,732
11,794
8,334
8,798
2,608
7,398
7,103
3,316
4,722
4,878
5,696
3,522
2,366
9,885
3,762
4,835
1,144
3,635
3,393
7,803
3,234
3,2347,8033,3933,6351,1444,8353,7629,8852,3663,5225,6964,8784,7223,3167,1037,3982,6088,7988,33411,79415,73211,1215,0173,7762,538000893
       Other Current Liabilities 
5,485
0
0
0
2,983
2,258
2,358
3,848
6,017
4,948
6,467
9,110
8,957
6,949
9,274
8,426
9,803
5,423
7,689
10,016
11,406
7,274
13,802
16,970
18,715
12,892
17,845
15,711
7,021
7,02115,71117,84512,89218,71516,97013,8027,27411,40610,0167,6895,4239,8038,4269,2746,9498,9579,1106,4674,9486,0173,8482,3582,2582,9830005,485
   > Long-term Liabilities 
0
0
0
0
30,360
169,161
32,641
37,063
38,944
41,115
40,923
40,255
39,686
44,795
43,970
40,962
45,084
16,060
14,807
13,540
24,844
23,902
23,587
28,338
27,916
27,475
27,023
26,560
221,555
221,55526,56027,02327,47527,91628,33823,58723,90224,84413,54014,80716,06045,08440,96243,97044,79539,68640,25540,92341,11538,94437,06332,641169,16130,3600000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
14,821
14,190
13,540
12,941
12,498
12,047
11,582
23,688
23,548
23,587
28,338
27,916
27,475
27,023
26,560
0
026,56027,02327,47527,91628,33823,58723,54823,68811,58212,04712,49812,94113,54014,19014,8210000000000000
       Warrants
0
0
0
0
0
275,524
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000275,52400000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
30,523
30,597
30,367
30,142
44,795
43,970
40,962
45,084
16,060
14,807
13,540
24,844
23,902
23,587
28,338
27,916
27,475
27,023
0
0
0027,02327,47527,91628,33823,58723,90224,84413,54014,80716,06045,08440,96243,97044,79530,14230,36730,59730,523000000000
       Deferred Long Term Liability 
0
0
0
0
1,000
31,399
32,641
37,063
38,944
266
10,326
9,888
9,544
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000009,5449,88810,32626638,94437,06332,64131,3991,0000000
> Total Stockholder Equity
7,500
-9,892
0
0
98,308
-49,525
226,798
212,760
194,717
174,264
284,742
257,822
258,507
226,541
194,704
170,222
195,995
200,829
224,577
198,571
169,651
266,254
240,288
209,061
177,978
151,899
119,375
88,211
72,991
72,99188,211119,375151,899177,978209,061240,288266,254169,651198,571224,577200,829195,995170,222194,704226,541258,507257,822284,742174,264194,717212,760226,798-49,52598,30800-9,8927,500
   Common Stock
1
0
0
0
3
0
4
4
3
3
4
4
4
4
4
4
5
5
6
6
6
6
6
6
6
6
6
6
6
66666666666554444443344030001
   Retained Earnings Total Equity00-493,025-457,981-429,137-394,842-361,116-332,027-424,132-390,549-359,941-329,441-328,368-298,577-270,345-235,005-199,674-175,507-145,880-119,610-97,396-78,394-63,599-50,70400000
   Accumulated Other Comprehensive Income 
0
0
0
0
-73
-86
-49
-21
-77
6
186
254
183
-19
11
-14,319
0
-23
2
-5
-7
0
-41
-457
-404
-182
-88
-36
-5
-5-36-88-182-404-457-410-7-52-230-14,31911-191832541866-77-21-49-86-730000
   Capital Surplus 
0
0
0
0
0
1,265
290,442
291,172
292,187
293,865
430,432
433,071
457,994
461,561
465,034
468,795
524,358
530,288
584,510
589,119
593,784
598,275
601,439
604,354
607,513
610,056
612,482
0
0
00612,482610,056607,513604,354601,439598,275593,784589,119584,510530,288524,358468,795465,034461,561457,994433,071430,432293,865292,187291,172290,4421,26500000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
138,560
-41,730
20,127
22,775
292,187
293,865
430,432
433,071
457,994
461,561
465,034
468,795
524,358
530,288
584,510
589,119
593,784
598,275
601,439
604,354
607,513
610,056
612,482
614,220
615,088
615,088614,220612,482610,056607,513604,354601,439598,275593,784589,119584,510530,288524,358468,795465,034461,561457,994433,071430,432293,865292,18722,77520,127-41,730138,5600000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,156
Cost of Revenue-578
Gross Profit578578
 
Operating Income (+$)
Gross Profit578
Operating Expense-92,680
Operating Income-92,102-92,102
 
Operating Expense (+$)
Research Development62,002
Selling General Administrative31,256
Selling And Marketing Expenses578
Operating Expense92,68093,836
 
Net Interest Income (+$)
Interest Income5,858
Interest Expense-0
Other Finance Cost-0
Net Interest Income5,858
 
Pretax Income (+$)
Operating Income-92,102
Net Interest Income5,858
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-87,080-97,124
EBIT - interestExpense = -92,102
-87,080
-112,961
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-92,102-87,080
Earnings Before Interest and Taxes (EBITDA)-91,524
 
After tax Income (+$)
Income Before Tax-87,080
Tax Provision--101
Net Income From Continuing Ops-131,137-86,979
Net Income-112,961
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses93,258
Total Other Income/Expenses Net5,022-5,858
 

Technical Analysis of Homology Medicines Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Homology Medicines Inc. The general trend of Homology Medicines Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Homology Medicines Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Homology Medicines Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.93 < 0.94 < 0.97.

The bearish price targets are: 0.7449 > 0.74 > 0.66.

Tweet this
Homology Medicines Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Homology Medicines Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Homology Medicines Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Homology Medicines Inc. The current macd is 0.03516611.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Homology Medicines Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Homology Medicines Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Homology Medicines Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Homology Medicines Inc Daily Moving Average Convergence/Divergence (MACD) ChartHomology Medicines Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Homology Medicines Inc. The current adx is 53.57.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Homology Medicines Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Homology Medicines Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Homology Medicines Inc. The current sar is 0.855.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Homology Medicines Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Homology Medicines Inc. The current rsi is 65.98. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Homology Medicines Inc Daily Relative Strength Index (RSI) ChartHomology Medicines Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Homology Medicines Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Homology Medicines Inc price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Homology Medicines Inc Daily Stochastic Oscillator ChartHomology Medicines Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Homology Medicines Inc. The current cci is 196.77.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Homology Medicines Inc Daily Commodity Channel Index (CCI) ChartHomology Medicines Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Homology Medicines Inc. The current cmo is 30.66.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Homology Medicines Inc Daily Chande Momentum Oscillator (CMO) ChartHomology Medicines Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Homology Medicines Inc. The current willr is -32.17021277.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Homology Medicines Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Homology Medicines Inc Daily Williams %R ChartHomology Medicines Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Homology Medicines Inc.

Homology Medicines Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Homology Medicines Inc. The current atr is 0.0519934.

Homology Medicines Inc Daily Average True Range (ATR) ChartHomology Medicines Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Homology Medicines Inc. The current obv is -4,496,370.

Homology Medicines Inc Daily On-Balance Volume (OBV) ChartHomology Medicines Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Homology Medicines Inc. The current mfi is 70.77.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Homology Medicines Inc Daily Money Flow Index (MFI) ChartHomology Medicines Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Homology Medicines Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-04MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Homology Medicines Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Homology Medicines Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.975
Ma 20Greater thanMa 500.907
Ma 50Greater thanMa 1000.780
Ma 100Greater thanMa 2000.727
OpenGreater thanClose0.920
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Homology Medicines Inc with someone you think should read this too:
  • Are you bullish or bearish on Homology Medicines Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Homology Medicines Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Homology Medicines Inc

I send you an email if I find something interesting about Homology Medicines Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Homology Medicines Inc.

Receive notifications about Homology Medicines Inc in your mailbox!